StemCell Therapy

Global cord blood banking market has emerged as one of the most crucial niche verticals of the healthcare industry, driven by the product demand in treatment of many life-threatening diseases including leukemia, thalassemia, and different kinds of cancers. As per The American Academy of Pediatrics, more than 30,000 stem cell transplants had been performed using cord blood by 2013, essentially demonstrating the criticality of stem cell cord blood banking institutions in treating fatal disorders with fewer complications and enhanced medical outcomes.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3268

Apart from affirmative policy statements and legislative provisions, the public cord blood banking market is gaining traction due to the fact that some nations such as Italy and France do not permit the establishment of private cord blood banks. Furthermore, an increasing number of funding programs by regional governments to overhaul stem cell cord blood banking research is augmenting the public cord blood banking industry. In fact, as per a research report by Global Market Insights, Inc., the revenue share of public cord blood banking industry is slated to exceed USD 3,931 million by 2025.

One of the main factors supporting the growth potential of public cord blood banking industry is the establishment of legislative provisions that ensure discoveries in the field of regenerative medicine and cellular therapy. In this regard, the Stem Cell Therapeutic and Research Act was established in the U.S. Senate and House Representatives during the year 2015.

India cord blood banking market has registered commendable gains due to the efforts undertaken by various NGOs spread across the country to offer funding for a public cord blood banks, in order to make stem cells available to the Indian population at an economical rate.

Some of the prominent companies in the industry globally include Cordlife, Global Cord Blood Corporation, Singapore Cord Blood Bank, and Jeevan Stem Cell Foundation, among many others.

A considerable increase in the number of patients diagnosed with life-threatening genetic disorders is a major factor supporting enhancements in cord blood banking industry. According to the World Health Organization, approximately 1 in 2000 newborn babies in the European Union are affected by cystic fibrosis. With the increasing prevalence of genetic disorders, the need for cord blood banking is likely to witness enormous growth in the future.

Request for customization @ https://www.decresearch.com/roc/3268

Partial Chapter of the Table of Content

Chapter 4. Cord Blood Banking Market, By Type of Bank

4.1. Key segment trends

4.2. Public

4.2.1. Market size, by region, 2014 2025 (USD Million)

4.3. Private

4.3.1. Market size, by region, 2014 2025 (USD Million)

Chapter 5. Cord Blood Banking Market, By Services

5.1. Key segment trends

5.2. Processing

5.2.1. Market size, by region, 2014 2025 (USD Million)

5.3. Storage

5.3.1. Market size, by region, 2014 2025 (USD Million)

5.4. Others

5.4.1. Market size, by region, 2014 2025 (USD Million)

Chapter 6. Cord Blood Banking Market, By Application

6.1. Key segment trends

6.2. Cancer

6.2.1. Market size, by region, 2014 2025 (USD Million)

6.3. Blood Disorders

6.3.1. Market size, by region, 2014 2025 (USD Million)

6.4. Immuno-deficiency disorders

6.4.1. Market size, by region, 2014 2025 (USD Million)

6.5. Metabolic disorders

6.5.1. Market size, by region, 2014 2025 (USD Million)

6.6. Bone marrow failure syndrome

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/cord-blood-banking-market

More here:
Cord Blood Banking Market Technological Innovations And Future Opportunities 202 - Fractovia News

This entry was posted on November 7, 2020 at 5:51 am and is filed under Stem Cell Complications. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |